The university is an anchor investor in a Black-owned venture capital firm’s first strategy that closed last month with more than $60 million in commitments.
The firm has entered into a “leaders strategy” partnership to form a platform that aims to acquire companies and assets in the technology-enabled pharmaceutical solutions industry.
The firm closed its third fund above its $550 million initial target with the support of existing investors and a substantial personal commitment from its team.
The plan terminated an approximately $799 million emerging markets equity mandate and made commitments with four existing managers and one new manager in September.